Login
Discover
Waves
Communities
Login
Signup
Topics
#immunodeficiency
Global
Trending
Hot
New
Top
#immunodeficiency
New
Top communities
Create your community
latest #immunodeficiency created topics | Ecency
genexi
health
2019-07-09 15:30
FDA Approves Xembify for Primary Immunodeficiencies
The US Food and Drug Administration (FDA) has approved Grifols’ first immunoglobulin Xembify®, 20% solution for the treatment of primary immunodeficiencies in patients as young as 2 years old.
$ 0.000
1
maheshgore
human
2018-07-24 12:39
!
Low reputation account with an unverified outbound link, Reveal content
Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Business Overview and Top Key Players - Gilead Sciences, AbbVie, Bristol-Myers Squibb Company
Human Immunodeficiency Virus (HIV)-1 Therapeutics Market size is projected to experience significant growth from 2017 to 2024. Human immunodeficiency virus therapeutics market size should witness tremendous
$ 0.000
0
1
market-report
primary
2018-06-28 10:58
Primary Immunodeficiency Diseases Treatment Market | 2017-2024 Industry Research Report
Primary Immunodeficiency Diseases Treatment Market evaluates the growth of the industry and estimates future prospects based on comprehensive research. Also provides the market size, share, growth, trends
rasavel2
adult-onset
2018-05-22 15:34
Adult-onset immunodeficiency syndrome
Adult-onset immunodeficiency syndrome is a provisional name for a newly diagnosed immunodeficiency illness. The name is proposed in the first public study to identify the syndrome.[1] It appears to be
skiptvads
Scrobble.life
2026-07-22 03:23
Promoted
[TV] For All Mankind (2019): No Sudden Moves - S05E06 - RECAP
Source I have been pushing on this one lately and now Im past half way of this season, its actually getting better and Episode 6 kept the same momentum as Episode 5 because the crisis on Mars finally has
bhardwaj
virus
2018-01-28 12:43
HIV: 35 years later
After 35 years of identifying HIV as a cause of AIDS, there is still stigmatization and ignorance. On January 23, 1983, Luc Montagnier, of the Pasteur Institute in Paris, identified for the first time
